Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Breathe helps relieve symptoms of asthma and COPD, promotes deeper breathing, targets mucus buildup, and provides a natural alternative to inhalers and steroids. Breathe is made from natural ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

The problem with COPD is you have obstruction ... people who have severe disease end up at a lung specialist for us to be able to institute those medications.

Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

For individuals with chronic lung conditions, the winter season and the current cold snap poses significant challenges.

The other single-inhaler on the market for COPD triple therapy ... The study was funded by the National Heart, Lung, and Blood Institute. Feldman disclosed relationships with Aetion and Alosa ...